Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. - Wikidata - awgldk - TriplyDB

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

http://www.wikidata.org/entity/Q44710572

about

Molecular substratification of bladder cancer: moving towards individualized patient management Emerging critical role of molecular testing in diagnostic genitourinary pathology A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential A Dual-Modality System for Both Multi-Color Ultrasound-Switchable Fluorescence and Ultrasound Imaging.Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat.Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.A network pharmacology approach to evaluating the efficacy of chinese medicine using genome-wide transcriptional expression data.Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer.A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting.SKIP expression is correlated with clinical prognosis in patients with bladder cancer.Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity Expression profiling for bladder cancer: strategies to uncover prognostic factors.Use of nomograms for predictions of outcome in patients with advanced bladder cancer.The promise of methylation on beads for cancer detection and treatment.Bladder cancer: a simple model becomes complex.Statistical consideration for clinical biomarker research in bladder cancer.Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.Tumor markers in prostate cancer I: blood-based markers.Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study.Predicting survival after radical cystectomy for bladder cancer.Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.Combining a molecular profile with a clinical and pathological profile: biostatistical considerations C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy.Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.Molecular determinants of tumor recurrence in the urinary bladder.Management of upper urinary tract urothelial carcinoma.Prognostic factors for upper urinary tract urothelial carcinoma.Immunohistochemical biomarkers for bladder cancer prognosis.Current status of molecular markers for prognostication and outcome in invasive bladder cancer.Biomolecular predictors of urothelial cancer behavior and treatment outcomes.Prognostic value of cell-cycle regulation biomarkers in bladder cancer.Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder.Molecular markers in bladder cancer: Novel research frontiers.Urine biomarkers of schistosomiais and its associated bladder cancer.

P2860

Q26744343-360C5CAB-0D85-42D8-89D7-9A4F6EB15FE1 Q27021371-891531DF-A0B9-4AE4-88E8-468E94B3DAB8 Q27022638-F03D57C1-21B5-4A75-A49B-4B5E603F6B21 Q30360896-268AEE80-48F3-45DA-AD43-2514F53CA95B Q30437629-02F3E802-83DA-468A-9ADD-370C64C67478 Q30438089-D9DAC134-264E-480C-9F19-2C8F117BFAF8 Q30640970-413BCFF2-B737-4F5C-813D-A5B4D8AD2C75 Q30968069-5BC2F94B-9D43-4546-B11B-6F960E916327 Q33439263-B1475D8A-15D5-466C-9E3D-F9A843CF4D62 Q33583048-70155C19-4D1C-467A-804B-4FEDD1CFEF96 Q34155874-CF0015AB-7CD7-46E4-AC94-0CC5417EFF3F Q34537170-E4B965CA-3AFF-4CEC-B06B-47D60EA4EB81 Q35076360-0565934B-1795-4890-A3E1-630ADEEBAB68 Q35594733-8480208A-65D7-45E8-A90E-3D83C5E9402E Q36108115-2AD5F83F-CFD1-4330-B1E3-43C72AE6E357 Q36124883-1CB0959D-3881-45A7-B34A-11962755469A Q36419132-95A96733-347A-4F11-8D7A-229B7794A2C1 Q36607766-2D452F20-EF58-43A4-B9D6-073C05695875 Q36623107-B1487694-465D-462D-A38F-9ED5154D2044 Q36956211-D6A80043-C62A-4E39-A4DE-B947528276B6 Q37053926-A5701296-78B1-408E-BE7B-881E3587C2A2 Q37103989-B3180CC7-DFDF-460F-8864-91D453570619 Q37181866-C0FC9546-0573-4D24-B482-9DD847C2FB71 Q37269864-257F48BC-0590-41AE-880A-40A8418C6E5C Q37279010-6D547DF5-3104-40A1-A90E-1000235686F2 Q37407271-F2F82FA0-609C-4678-AA8A-A8767C85F811 Q37445971-52CFB3D5-79E8-4AB1-8F97-B05F24DDB441 Q37575626-151076DF-7013-4F31-9BA0-501C9A32C262 Q37812609-33448231-14A6-4945-99D6-7AD8B91399CF Q37897483-F2D0912A-01D2-4B75-8419-5FBBA36FD5CF Q37902697-FDA0B884-30BE-4A58-A495-28F715458AD4 Q37974674-E433B890-D38A-4F54-8D7D-51BE48E7EA1D Q37987066-1D1F672E-FF8E-4372-BF8F-05679A88B37D Q38049692-303EA83C-8C71-4584-8B73-CF62A99D2DB2 Q38196442-5B1B37EE-1D45-45F5-98EB-B3AF191CECD6 Q38230912-C84EE5C6-E78D-4C66-A65B-2C729E94075B Q38413564-D6455FC4-F6B6-40C2-9F4A-C360E9D02671 Q38440895-113F4BE8-498C-460E-A4B7-B09261FACEAF Q38520403-B249ECE5-A5FA-41F5-ACAA-3762A64814BC Q38536270-EBA9F241-9E5D-48F6-82B1-9059FBDF0F3D

P2860

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

http://www.wikidata.org/entity/Q44710572

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@en

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@nl

type

label

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@en

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@nl

prefLabel

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@en

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@nl

P1433

Q44710572-5933752A-4345-4D32-8B7B-B490672A3B32

P1476

Q44710572-5522E6D3-F1D3-417E-B45B-361A9BF3FCB5

P2093

Q44710572-00823848-DB6A-454E-902C-EE31147963B4

Q44710572-5F5DC3C7-3DA1-4C3F-9B74-63C4560071F4

Q44710572-88758C6E-FB8E-4194-B227-403724B7D473

Q44710572-8A75E7FA-D3F2-445B-9FEA-5853DA69F8A9

Q44710572-8E81E05F-8C83-411F-A983-6368FBC614E8

Q44710572-9EAC353B-3F0C-4C23-94D1-71468566357F

Q44710572-B3DC15EA-A516-4918-BBAE-55DBE62D60C8

P2860

Q44710572-2A8F49B7-B661-49BB-B16F-701B583AC827

Q44710572-A9D9C903-68B1-41A8-8FC8-2A7C08C3302E

P304

Q44710572-0525BF0F-A657-4A8B-83E8-220F4B0D1949

P31

Q44710572-AD4CA8C3-8FAA-4D6E-A60A-72C5121AFEE2

P356

Q44710572-F67233B2-F4D5-4CCF-9444-90A883082EB7

P407

Q44710572-0B2E76A7-4D6D-4413-A1F7-B00F315BEF8D

P433

Q44710572-2C053F92-9F92-442D-BE07-A3156516F87F

P478

Q44710572-17201F54-8555-4C28-B4EA-E545CF3892EE

P50

Q44710572-CE697DF3-601E-4195-93C9-B4878F18B5F6

P577

Q44710572-0A1BDA1D-859C-4E7C-A7BD-765FDEBDA29A

P5875

Q44710572-6F6A907B-FFBC-493B-9907-92F00FBB3D56

P698

Q44710572-26C82CCF-9203-4506-999F-58D18503B177

P921

Q44710572-19A47757-B56A-4336-A557-1FDD80C938B5

Q44710572-B9C4B6BC-9020-4EEB-ACA0-DDC991FAF8C8

P356

P1433

P1476

Multiple biomarkers improve pr ...... atients undergoing cystectomy.

@en

P2093

Arthur I Sagalowsky

http://www.w3.org/2001/XMLSchema#string

Ganesh S Palapattu

http://www.w3.org/2001/XMLSchema#string

Pierre I Karakiewicz

http://www.w3.org/2001/XMLSchema#string

Raheela Ashfaq

http://www.w3.org/2001/XMLSchema#string

Richard J Cote

http://www.w3.org/2001/XMLSchema#string

Seth P Lerner

http://www.w3.org/2001/XMLSchema#string

Shahrokh F Shariat

http://www.w3.org/2001/XMLSchema#string

P2860

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.

Bladder cancer clinical trials.

P304

315-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.23162

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5839431

http://www.w3.org/2001/XMLSchema#string

P698

18008359

http://www.w3.org/2001/XMLSchema#string

P921